NCT03830515 is a NA clinical trial of microMend in Lacerations, sponsored by KitoTech Medical, Inc..

Who is sponsoring NCT03830515?

NCT03830515 is sponsored by KitoTech Medical, Inc..

What drugs are being tested in NCT03830515?

Interventions in NCT03830515: microMend.

What condition does NCT03830515 study?

NCT03830515 studies Lacerations, Wounds.

Is NCT03830515 still recruiting?

NCT03830515 is currently status unknown. Last updated 5 February 2019.

Last reviewed 2019-02-05 · How we verify

NCT03830515

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of microMend Device to Close Lacerations

Status unknown NA Last updated 5 February 2019

What this trial tests

NA trial testing microMend in Lacerations in 30 participants. Status unknown.

Timeline

20 April 2018

Primary endpoint
31 October 2019

31 December 2019

Quick facts

Lead sponsor	KitoTech Medical, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	20 April 2018
Primary completion	31 October 2019
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

microMend

Conditions studied

Lacerations — all drugs for Lacerations →
Wounds — all drugs for Wounds →

Sponsor

KitoTech Medical, Inc.

Who can join

Adults 18 to 75, any sex, with Lacerations or Wounds. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, total of 20 subjects will have lacerations will be closed with microMend, which is an FDA-listed wound closure product. microMend is a wound closure device that is the size and shape of a butterfly bandage and incorporates tiny Microstaples into an adhesive backing. Assessments by practitioners and Subjects of microMend will be made at Days 0 10, and 3 months using a combination of questionnaires and photographs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of microMend wound closure device in repairing skin lacerations.
Nizami T, Beaudoin F, Suner S, Aluisio A, et al · · 2023 · PMID 37220958 · DOI 10.1136/emermed-2022-212667

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03830515 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by KitoTech Medical, Inc.
Last refreshed: 5 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03830515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing